Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?



Rating:

Share or cite this content

Citations should be made in the following way:
Bernd Schmidt (Halle, Germany), Bernd Schmidt, Hubertus Rolke, Clemens Oerding, Michael Fleischhacker. CellCollector®: A novel method for the isolation of circulating tumor cells (CTC) in vivo and ex vivo in lung cancer patients during therapy. Eur Respir J 2016; 48: Suppl. 60, 526

Member's Comments

No comment yet.

Related content which might interest you: In vitro and in vivo application of the GILUPI cell collector system for the isolation and characterization of circulating tumor cells (CTCs) in lung cancer patients Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 Anti-cancer effects of bevacizumab and cisplatin on cancer cell invaded human ex-vivo lung tissue Source: International Congress 2016 – Lung cancer and immune cells: friends or foes? Year: 2016 CD33+CD14-CD11b+CD66b+CD15+VEGFR-1hi myeloid derived suppressor cells and their clinical relevance in non-small cell lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Abnormal abundance of senescent fibroblasts in the tumor stroma of non-small cell lung cancer patients Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 Increased expression of WSX1 on alveolar lymphocytes (AL) in patients with early stage non-small cell lung cancer (NSCLC). Preliminary report Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Early response detection in systemic lung cancer treatment using cell-free methylated SHOX2 (mSHOX2) plasma DNA Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 A tissue microarray analysis on the role of chromosome 7 multiplication regarding the EGFR expression in non-small cell lung carcinomas Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016 Antitumor efficacy of the double suicide genesin lung cancer cells Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Biological factors predicting response to chemotherapy (CT) in advanced non small cell lung cancer (NSCLC): A feasibility study on the collection of tissue Source: Annual Congress 2010 - The role of biomarkers in lung cancer Year: 2010 EGFRmutations are associated with higher brain metastasis radio-sensitivity than KRAS mutations or wild type EGFR in non-small cell lung cancer patients (NSCLC) Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Adenylate cyclase-associated protein 1 is associated with metastasis of non-small cell lung cancer especially in brain metastasis patients and promotes the lung cancer cell proliferation and migration in vitro as well as its growth and metastasis in vivo by the signaling pathways of limk1-cofilin Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours Year: 2015 A polymorphism, which exists intronic lesion of SLC5A10, affects DRG2 expression and survival outcome of early-stage non-small cell lung cancer Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Correlation of IL-17A concentration with T regulatory cells in lung cancer microenvironment Source: International Congress 2016 – Lung cancer and immune cells: friends or foes? Year: 2016 Roles of polarized neutrophils on lung tumour development in an orthotopic lung tumour mouse model Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 Cox-2 inhibitors in the treatment of small cell lung cancer patients Source: International Congress 2015 – Advances in the therapy of lung cancer Year: 2015 Mouse lung adenocarcinoma cell lines reveal Prl2c2 as a novel lung tumor promoter Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours Year: 2015 The active compound of garlic to treat non-small cell lung cancer: in vitro studies Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 Rhesus CE expression is an independent prognostic factor in non-small cell lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Lactat-dehydrogenase, C-reactive protein and white blood cell count are prognostic factors in advanced small cell lung cancer (SCLC) Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Changes in lymphocyte subgroups of non-small cell lung cancer patients during chemotherapy Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015